Detection of immune cells, in particular T cells through DNA-methylation analysis of the genes CCR6 and BLR1
US 10,590,475 In forceTerm ends Apr 29, 2031 · From the USPTO record
20-year base term ends Apr 29, 2031
Apr 29, 2011
Apr 29, 2031
Mar 17, 2020
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 29, 2011, when the earliest non-provisional application in its chain was filed (this one was filed Jul 27, 2017); a parent in its chain could not be resolved (the next row) | Apr 29, 2031 | USPTO record |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | USPTO record |
| Patent term adjustment | No term adjustment record on a grant after 2005, so none is added | no change | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 1 of 2 maintenance fees paid | In force | USPTO record |
| Computed term end | The steps above, in order | Apr 29, 2031 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.